Lista de obras -

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology

artículo científico publicado en 2017

A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer

artículo científico publicado en 2018

A comparison of prostate cancer bone metastases on F-Sodium Fluoride and Prostate Specific Membrane Antigen (F-PSMA) PET/CT: Discordant uptake in the same lesion

artículo científico publicado en 2018

Advancement of MR and PET/MR in Prostate Cancer

artículo científico publicado en 2016

Advances in medical imaging for the diagnosis and management of common genitourinary cancers

artículo científico publicado en 2017

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

artículo científico publicado en 2015

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI

scientific article published on 07 July 2020

Evaluation of Prostate Cancer with PET/MRI.

artículo científico publicado en 2016

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study

artículo científico publicado en 2019

Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study

artículo científico publicado en 2017

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents

Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options

scientific article published on 17 April 2020

Novel Imaging in Detection of Metastatic Prostate Cancer

artículo científico publicado en 2019

Oncologic Angiogenesis Imaging in the clinic---how and why.

artículo científico publicado en 2011

PET imaging of recurrent and metastatic prostate cancer with novel tracers

artículo científico publicado en 2016

Positron emission tomography (PET) radiotracers for prostate cancer imaging

scientific article published on 11 February 2020

Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.

artículo científico publicado en 2016

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer-Reply

artículo científico publicado en 2018

Reply: To PMID 22343504.

artículo científico publicado en 2013

Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging

artículo científico publicado en 2015

The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology

artículo científico publicado en 2012

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2015

[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrins.

artículo científico publicado en 2014

Lista de obras de

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology

A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer

A comparison of prostate cancer bone metastases on F-Sodium Fluoride and Prostate Specific Membrane Antigen (F-PSMA) PET/CT: Discordant uptake in the same lesion

Advancement of MR and PET/MR in Prostate Cancer

Advances in medical imaging for the diagnosis and management of common genitourinary cancers

Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging

Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of 18F-DCFPyL PET/CT with Comparison to Multiparametric MRI

Evaluation of Prostate Cancer with PET/MRI.

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study

Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot study

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents

Local failure after definitive radiation treatment of lymph-node positive prostate cancer: supporting the use of novel imaging techniques to personalize treatment options

Novel Imaging in Detection of Metastatic Prostate Cancer

Oncologic Angiogenesis Imaging in the clinic---how and why.

PET imaging of recurrent and metastatic prostate cancer with novel tracers

Positron emission tomography (PET) radiotracers for prostate cancer imaging

Prospective Study Evaluating Na18F PET/CT in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer-Reply

Reply: To PMID 22343504.

Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging

The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

[¹⁸F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing αvβ 3 and α vβ 5 integrins.